Sign In
Buy FMS
$25.66
-0.0400 (-0.156%)
At Close: Jul 31, 2026
Fresenius Medical (FMS) Divests Assets to Optimize Portfolio
10:46am, Monday, 11'th Mar 2024
Fresenius Medical's (FMS) latest asset divestments reflect a milestone in its portfolio optimization program and are likely to improve profitability.
Divestment of assets includes four separate country transactions to DaVita Inc. for USD 300 million Transactions further reduce the Company`s clinic footprint in Latin America, following the exit from
Fresenius Medical (FMS) Q4 Earnings Beat, Operating Margin Up
08:56am, Wednesday, 21'st Feb 2024
Fresenius Medical's (FMS) fourth-quarter revenues suffer due to unfavorable currency movement. However, the company?
Fresenius Medical Care AG (FMS) Q4 2023 Earnings Call Transcript
12:03pm, Tuesday, 20'th Feb 2024
Fresenius Medical Care AG (FMS) Q4 2023 Earnings Call Transcript
Fresenius Medical Care delivers on commitments in a year of fundamental transformation
07:30am, Tuesday, 20'th Feb 2024
Revenue growth of 5% in 2023 driven by favorable business development Operating income1 growth of 15% exceeding top end of outlook range, due to business growth, FME25 savings ahead of plan and contri
Fresenius Medical (FMS) Gets FDA Nod for New Hemodialysis System
11:51am, Friday, 09'th Feb 2024
Fresenius Medical (FMS) receives an FDA nod for its new 5008X Hemodialysis System that aims to provide better dialysis therapy for kidney patients in the United States.
Fresenius Medical Care (FME) receives U.S. Food and Drug Administration (FDA) 510(k) clearance of the company's 5008X Hemodialysis System. This will enable Fresenius Medical Care to offer the industry
Fresenius Medical Care AG nominates Six Employee Representatives to the Supervisory Board
08:57am, Monday, 05'th Feb 2024
BAD HOMBURG, Germany , Feb. 5, 2024 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, has nominated six employee
Fresenius Medical (FMS) Divests Businesses to Optimize Portfolio
11:16am, Tuesday, 09'th Jan 2024
Fresenius Medical (FMS) streamlines for success with three key divestments in 2023. These divestments are likely to impact operating income by EUR 500 million in the fourth quarter.
Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now
02:16pm, Wednesday, 20'th Dec 2023
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
Fresenius plans to sell rehabilitation care clinics - FAZ
09:55am, Friday, 08'th Dec 2023
Fresenius has hired UBS to manage the sale of its rehabilitation care clinic business as the German healthcare group focuses on core activities, Frankfurter Allgemeine Zeitung reported on Friday, citi
Fresenius Medical Care says data on 500,000 people stolen in U.S.
09:52am, Wednesday, 06'th Dec 2023
Dialysis group Fresenius Medical Care said on Wednesday that data including medical records on 500,000 patients and former patients were stolen from a U.S. subsidiary's database.
Fresenius Medical (FMS) Ups '23 Outlook After Legal Settlement
08:16am, Thursday, 23'rd Nov 2023
Fresenius Medical (FMS) wins legal dispute against the U.S. government. Both revenues and operating income will benefit from the settlement agreement.
Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now
09:46am, Wednesday, 22'nd Nov 2023
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
Who's afraid of Ozempic? From restaurants to package makers, companies work to calm investors' GLP-1 jitters.
11:13am, Friday, 10'th Nov 2023
That's the message from many corporate executives who have lately been peppered with questions about how Wegovy, Ozempic and other drugs widely used for weight loss may impact their bottom line.
